Jia-Wen Deng

Regulatory Framework and Clinical Translation of Automated Cell Production in China

The synthesis of regulatory policy and clinical evidence demonstrates that automated production is not only a compliance requirement but a critical determinant of therapeutic efficacy and patient safety in China's rapidly advancing regenerative medicine sector.